Objective Transcatheter aortic valve implantation (TAVI) has emerged as an alternative
treatment to aortic valve replacement (AVR) for selected patients with severe aortic stenosis …

Objective: Transcatheter aortic valve implantation (TAVI) has emerged as a feasible
alternative treatment to conventional surgical aortic valve replacement (AVR) for high-risk …

Background One-year mortality outcomes in the PARTNER trial showed that transcatheter
aortic valve implantation (TAVI) was noninferior to surgical aortic valve replacement (sAVR) …

Introduction Transcatheter aortic valve intervention (TAVI) is known to be non-inferior to
surgical aortic valve replacement (SAVR) in low-intermediate surgical risk patients. This …

The aim of this study was to compare in-hospital cost and outcomes between transcatheter
aortic valve implantation (TAVI) and surgical aortic valve replacement (SAVR). TAVI is an …

Background The Placement of Aortic Transcatheter Valve (PARTNER) trial suggested an
economic advantage for transcatheter aortic valve replacement (TAVR) for high-risk patients …

The cost of transcatheter aortic valve replacement (TAVR) has been studied in the context of
high-risk or specific comorbidity populations; this paper provides a comprehensive overview …

Abstract Background The recent PARTNER S3i trial compared transcatheter aortic valve
implantation (TAVI) using the third-generation SAPIEN 3 device to surgical aortic valve …

Objective To determine the cost-effectiveness of transcatheter aortic valve implantation
(TAVI) compared with surgical aortic valve replacement (SAVR) in a high-risk aortic stenosis …

Objectives: The aim of this study was to evaluate the cost-effectiveness of transcatheter
aortic valve replacement (TAVR) compared with surgical aortic valve replacement (AVR) for …